| United Therapeutics Drug Flunks Small Cell Lung Cancer Clinical Trial | Frank Vinluan | 02/03/20 | National |
| Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More | Frank Vinluan | 11/16/18 | National |
| Arena’s Comeback Continues with $800M Deal for Lung Disease Drug | Frank Vinluan | 11/15/18 | San Diego |
| Y-mAbs Upsizes IPO, Gets $96M to Test Two Pediatric Cancer Drugs | Frank Vinluan | 09/21/18 | New York |
| Y-mAbs Plans IPO to Advance Two Pediatric Cancer Drugs to the FDA | Frank Vinluan | 08/27/18 | New York |
| Nanotech Liquidia Hops IPO Wave as Lead Drug Faces Late-Stage Test | Frank Vinluan | 06/29/18 | Raleigh Durham |
| Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More | Ben Fidler | 05/04/18 | National |
| United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed | Frank Vinluan | 04/30/18 | San Francisco |
| Celularity Raises $250M to Make Stem Cell Treatments for Cancer & More | Frank Vinluan | 02/15/18 | New York |
| TAI Diagnostics Raises $10M, Inks Deal With United Therapeutics | Jeff Buchanan | 01/11/18 | Wisconsin |
| CRISPR Organs? eGenesis Raises $38M For Pig-To-Human Transplants | Alex Lash | 03/16/17 | Boston |
| Cashing in On Duchenne Approval, Sarepta Sells Voucher to Gilead For $125M | Ben Fidler | 02/21/17 | Boston |
| FDA Rejects Cempra Antibiotic, Asks for Another Clinical Trial | Frank Vinluan | 12/29/16 | Raleigh Durham |
| With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher | Ben Fidler | 08/31/15 | New York |
| GSK Restructuring Slashes R&D; RTP to Take Brunt of Cuts | Frank Vinluan | 12/04/14 | Raleigh Durham |
| West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More | Bruce V. Bigelow | 05/09/14 | San Diego |
| Deal Aims to Grow “Humanized” Organs in Pigs for Transplantation | Bruce V. Bigelow | 05/06/14 | San Diego |
| Aires Pharmaceuticals Emerges from Stealth Mode With Drug for Pulmonary Arterial Hypertension | Luke Timmerman | 11/05/08 | San Diego |
